Consistent with this report, cleavage of caspase-2 and MDM2, but not caspase-3, and induction of p53 expression were observed in MYCN-amplified NB cells at 72 h after transfection of CRISPR/dCas9 (Figure 3E). The gene discussed is MYCN; the disease is neuroblastoma.